1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 21,400 | 22,000 | 07.08. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| GETINGE AB ADR Aktie jetzt für 0€ handeln | |||||
| Mi | Getinge's NAVA technology featured on national television | 1 | Cision News | ||
| 17.07. | Getinge Q2 2026 slides: margin expansion, strong cash flow drive rally | 1 | Investing.com | ||
| 17.07. | Getinge AB Q2 Income Rises | 2 | RTTNews | ||
| 17.07. | Getinge AB (publ) reports Q2 results | 11 | Seeking Alpha | ||
| 17.07. | Getinge Aktie legt nach starkem Q2 dank Zollerstattungen und Preiserhöhungen kräftig zu | 5 | Investing.com Deutsch | ||
| 17.07. | Getinge AB: Getinge Interim Report April-June 2026: Good organic growth, high profitability and strong cash flow | 172 | GlobeNewswire (Europe) | Press release
Gothenburg, Sweden on July 17, 2026
"We delivered a strong quarter both financially and operationally with several important key achievements", says Mattias Perjos, President and CEO... ► Artikel lesen | |
| 09.07. | Getinge zieht als neuer Mieter ins HEADS Office bei München | 2 | DEAL-Magazin | ||
| 07.07. | Getinge supports neonatal critical care training in India | 1 | Cision News | ||
| 03.07. | Getinge receives refund of tariffs paid under IEEPA | 2 | Cision News | ||
| 03.07. | Getinge invites fund managers, analysts, and media to Q2 Report 2026 conference call | 1 | Cision News | ||
| 26.06. | Getinge opens digital OR hub in Germany | - | MassDevice | ||
| 26.06. | New hub accelerates Getinge's digital healthcare innovation | 2 | Cision News | ||
| 18.06. | Getinge launches Fluobeam LS, advancing fluorescence imaging for small-incision procedures | 2 | Cision News | ||
| 11.06. | Getinge elevates automated endoscope reprocessing with Aquadis Endo 110 | 2 | Cision News | ||
| 02.06. | Getinge Launches Vasoview Hemopro 3, Advancing Endoscopic Vessel Harvesting | 2 | Cision News | ||
| 28.05. | Massachusetts court sides with Abiomed in Getinge patent spat | 5 | MassDevice | ||
| 28.05. | Getinge's subsidiary Maquet Cardiovascular receives adverse jury trial verdict in patent infringement dispute with Abiomed in the U.S. | 2 | Cision News | ||
| 27.04. | Getinge boosts GSS67N sterilizer throughput with expanded validated load capacity at HSPA 2026 | 10 | Cision News | ||
| 21.04. | Getinge AB: Resolutions at Getinge's Annual General Meeting April 21, 2026 | 397 | GlobeNewswire (Europe) | Press Release
Gothenburg, Sweden on April 21, 2026
Getinge AB (publ)'s Annual General Meeting ("AGM") was held on April 21, 2026 in Kongresshallen, Hotel Tylösand, Halmstad, Sweden. At the AGM, the... ► Artikel lesen | |
| 21.04. | Getinge AB Non-GAAP EPS of SEK 1.80; maintains FY26 forecast of organic sales growth | 5 | Seeking Alpha |
1 2 Weiter >>
33 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 42,050 | +0,41 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| ESSILORLUXOTTICA | 172,60 | -0,17 % | RBC stuft EssilorLuxottica auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat die Einstufung für EssilorLuxottica nach Halbjahreszahlen auf "Outperform" mit einem Kursziel von 230 Euro belassen. Das beständig im mittleren... ► Artikel lesen | |
| ALIGN TECHNOLOGY | 146,95 | -2,20 % | Align Technology To Add Three Directors And Raise 2026 Share Repurchases To Up To $500 Million | ||
| INMODE | 13,225 | 0,00 % | InMode Ltd.: InMode Reports Second Quarter 2026 Financial Results: Quarterly GAAP Revenues of $95.6 Million, Consistent with the Second Quarter of 2025 | YOKNEAM, Israel, Aug. 5, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced... ► Artikel lesen | |
| INVITAE | - | - | Patentstreit: Natera sichert sich 30 % Lizenzgebühr von Invitae | ||
| ELEVANCE HEALTH | 340,60 | -0,12 % | Elevance Health Raises FY26 Guidance; Expects To Return To At Least 12% Adj. EPS Growth In 2027 | WASHINGTON (dpa-AFX) - Elevance Health (ELV) said second quarter results exceeded its outlook. The company increased 2026 EPS guidance to at least $20.10, and lifted 2026 adjusted EPS guidance... ► Artikel lesen | |
| BONESUPPORT | 20,480 | +0,20 % | Bonesupport Holding AB: BONESUPPORT HOLDING AB (publ) - publishes Q2 2026 interim report | BONESUPPORT HOLDING AB (publ), a leading company in orthobiologics for the management of bone injuries, today publishes the interim report for the second quarter 2026.
"Strong growth and improved operating... ► Artikel lesen | |
| TENET | 224,00 | -1,75 % | Tenet Healthcare Aktie markiert neues Rekordhoch bei 262,69 USD | ||
| ARJO | 2,496 | -0,24 % | Arjo AB: Arjo's interim report January-June 2026 | "We grew by 4.7% organically in the quarter, driven by high demand for our products and solutions. We are also now taking important steps to enhance our focus, efficiency, and profitability - and to... ► Artikel lesen | |
| AMN HEALTHCARE SERVICES | 30,800 | -1,28 % | AMN Healthcare Services, Inc.: Amn Healthcare Announces Second Quarter 2026 Results | Quarterly revenue of $673 million and adjusted EBITDA of $73 million;
GAAP income of $0.53/share and adjusted EPS of $0.77
DALLAS, Aug. 6, 2026 /PRNewswire/ --... ► Artikel lesen | |
| ALPHATEC | 7,700 | -4,35 % | Alphatec signals $140M adjusted EBITDA guidance for 2026 while maintaining ~$882M revenue outlook | ||
| CHECK-CAP | 1,190 | +9,17 % | Check-Cap announces 1-for-7 reverse stock split | ||
| FISHER & PAYKEL HEALTHCARE | 21,000 | -0,94 % | Dividendenbekanntmachungen (22.06.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACEA SPA IT0001207098 - 1,2 EUR AIR ASTANA JSC GDR US0090632078 0,0835 USD 0,0728 EUR ALTEN SA FR0000071946 - 1,5 EUR ANTAM PERSERO... ► Artikel lesen | |
| OSSDSIGN | 0,373 | +2,62 % | OssDsign AB: OssDsign appoints Adam McCollister as new Vice President of Sales | OssDsign Appoints Adam McCollister as Vice President of Sales to Accelerate U.S. Growth of Catalyst Platform
Uppsala, Sweden, June 25, 2026 - OssDsign AB (publ.), a leader in next-generation orthobiologic... ► Artikel lesen | |
| STEREOTAXIS | 1,206 | +3,25 % | Stereotaxis, Inc.: University of Szeged Pioneers First Robotic Cardiology Program in Hungary | First Robotic Magnetic Navigation system installed in HungaryUniversity of Szeged, led by Cardiology Chief Dr. Szili-Torok, expected to treat hundreds of patients annually with all forms of cardiac... ► Artikel lesen |
Das Unternehmen GETINGE AB ADR kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,200 (-0,94 %) liegt der Kurs bei 21,000 Euro. Die Dividendendrendite beträgt aktuell 0,00 % (berechnet anhand der Ausschüttung von 0,00 Euro in den letzten 12 Monaten).
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GETINGE AB ADR finden Sie auf Wallstreet Online.